首页 › 基金 › NEXTBio Capital Management LP › IRON
NEXTBio Capital Management LP 对 IRON 的持仓历史
DISC MEDICINE INC · 医疗保健
NEXTBio Capital Management LP 在 Q3 2026 的 13F 申报中披露持有 IRON(DISC MEDICINE INC)52,655 股,市值约 US$3.4M,约占其申报组合的 1.50%,在其申报持仓中市值排名第 20 位。 NEXTBio Capital Management LP 最近 4 个申报季度中有 4 个季度披露了 IRON 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
NEXTBio Capital Management LP 对 IRON 的持仓演变
NEXTBio Capital Management LP 于 Q4 2025 首次披露 IRON 持仓:42,778 股(约 US$3.4M)。 该持仓在 Q2 2026 达到峰值 52,655 股,市值约 US$3.9M。 在 4 次申报中,NEXTBio Capital Management LP 1 次增持、0 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 52,655 股、市值约 US$3.4M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 42.78K | $3.40M | 新进 |
| Q1 2026 | 52.66K | $3.37M | 增持 |
| Q2 2026 | 52.66K | $3.85M | 持有 |
| Q3 2026 | 52.66K | $3.45M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 IRON 与 13F 数据
IRON(DISC MEDICINE INC)属于医疗保健行业。我们追踪的基金中还有 38 只申报持有 IRON,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$179.2M), Vestal Point Capital, LP (US$113.4M), Frazier Life Sciences Management, L.P. (US$99.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 IRON 的基金
- RA CAPITAL MANAGEMENT, L.P. 2.45M 股 · $179.21M · Q2 2026
- Vestal Point Capital, LP 1.55M 股 · $113.37M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.35M 股 · $99.09M · Q2 2026
- TCG Crossover Management, LLC 1.34M 股 · $98.14M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 1.38M 股 · $90.60M · Q3 2026
- BVF INC/IL 1.15M 股 · $84.38M · Q2 2026
- Logos Global Management LP 875.00K 股 · $64.00M · Q2 2026
- Opaleye Management Inc. 855.00K 股 · $62.53M · Q2 2026
- Siren, L.L.C. 888.40K 股 · $58.15M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 657.00K 股 · $48.05M · Q2 2026
- Bellevue Group AG 560.00K 股 · $40.96M · Q2 2026
- Saturn V Capital Management LP 524.73K 股 · $38.38M · Q2 2026
更多关于 NEXTBio Capital Management LP
常见问题
How long has NEXTBio Capital Management LP held IRON?
NEXTBio Capital Management LP has disclosed IRON holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is NEXTBio Capital Management LP's current position in IRON?
As of Q3 2026, NEXTBio Capital Management LP holds 52.66K shares of IRON (DISC MEDICINE INC), valued at $3.45M, representing 1.50% of its reported portfolio and ranking #20.
Has NEXTBio Capital Management LP been buying or selling IRON?
In the latest 13F filing (Q3 2026), NEXTBio Capital Management LP held unchanged its position in IRON. The position peaked in Q2 2026 at 52.66K shares.
Which other funds hold IRON?
Other major institutional holders of IRON include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Frazier Life Sciences Management, L.P., among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.